Skip to content

Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions

Prospective, Single-Center Evaluation of Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Distal Embolic Protection for Chronic Total Occlusions of the Superficial Femoral Artery

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07803718
Enrollment
60
Registered
2026-09-04
Start date
2026-09-01
Completion date
2028-09-01
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherectomy in Diseased Lower Extremity Arteries, Peripheral Artery Disease

Keywords

Rotational Atherectomy, Distal Embolic Protection, Endovascular Revascularization

Brief summary

Peripheral artery disease can reduce blood flow to the legs. In some patients, the superficial femoral artery, a major artery in the thigh, is completely blocked over a long segment. This study will evaluate a minimally invasive treatment for these blockages. Approximately 60 adults who require endovascular treatment will undergo placement of a filter beyond the blockage to collect debris. Rotational atherectomy will then be used to remove part of the material causing the blockage, followed by drug-coated balloon angioplasty to widen the artery. A stent may be placed only if needed because of an inadequate treatment result or a procedure-related complication. Participants will be evaluated by clinical examination and duplex ultrasound at 1, 3, 6, and 12 months. The main goal is to determine how often the treated artery remains open at 12 months. The study will also evaluate technical success, the need for repeat treatment, material captured by the filter, and procedure-related blockage of smaller downstream arteries.

Interventions

DEVICERotational Atherectomy With Distal Embolic Protection and Drug-Coated Balloon Angioplasty

After successful crossing of the superficial femoral artery chronic total occlusion, a distal embolic protection filter will be deployed in the distal superficial femoral or popliteal artery. Rotational atherectomy will be performed to debulk atherosclerotic and thrombotic material, followed by drug-coated balloon angioplasty. Bailout stenting may be performed for flow-limiting dissection, significant residual stenosis, or another inadequate angiographic result.

Sponsors

Sakarya University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All participants will receive distal embolic protection, rotational atherectomy, and drug-coated balloon angioplasty.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older Symptomatic peripheral artery disease classified as Rutherford category 2 to 5 Chronic total occlusion of the superficial femoral artery extending from its origin toward Hunter's canal Clinical indication for endovascular treatment At least one patent distal runoff artery

Exclusion criteria

* Acute limb ischemia Severe renal impairment contraindicating iodinated contrast administration Coagulopathy Absence of a patent distal runoff artery

Design outcomes

Primary

MeasureTime frameDescription
Primary Patency of the Treated Superficial Femoral Artery Segment at 12 Months12 months after the index procedureThe proportion of participants with a patent treated superficial femoral artery segment on duplex ultrasonography, defined as a peak systolic velocity ratio of less than 2.4.

Secondary

MeasureTime frameDescription
Primary Patency of the Treated Superficial Femoral Artery Segment at 1, 3, and 6 Months1, 3, and 6 months after the index procedureThe proportion of participants with a patent treated superficial femoral artery segment at each scheduled follow-up, assessed by duplex ultrasonography and defined as a peak systolic velocity ratio of less than 2.4.
Target Lesion RevascularizationThrough 12 months after the index procedureThe proportion of participants requiring repeat endovascular or surgical revascularization of the treated SFA segment.
Periprocedural Distal EmbolizationPeriproceduralThe proportion of participants with clinically evident or angiographically confirmed distal embolization associated with the index procedure.
Macroscopic Material Captured in the Distal Embolic Protection FilterImmediately after the index procedureThe proportion of retrieved distal embolic protection filters containing macroscopically visible thrombotic or atheromatous debris.
Technical Success of the Index ProcedureAt the end of the index procedureThe proportion of procedures in which the target lesion is successfully crossed and treated with rotational atherectomy and drug-coated balloon angioplasty, with restoration of antegrade flow on final angiography.

Countries

Turkey (Türkiye)

Contacts

CONTACTÖMER FARUK TOPALOĞLU, MD
ofaruktopaloglu@gmail.com+90 264 888 40 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026